p53, p21 and mdm2 expression vs the response to radiotherapy in transitional cell carcinoma of the bladder

Ranveig Røtterud(Norwegian Cancer Society), Sophie D. Fosså(Oslo University Hospital), A. Berner, Ruth Holm(University of Aleppo), Eva Skovlund(Norwegian University of Science and Technology)
British Journal of Urology
August 1, 2001
10.1046/j.1464-410x.2001.02268.x
Cited by 22

Related Papers

Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
|New England Journal of Medicine|2013|3.3k
Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome.
|PubMed|1993|589
Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian Cancers
|PLoS ONE|2011|222
Small cell carcinoma of the cervix. A clinicopathologic study of 26 patients
|Cancer|1994|201
Prognostic significance of TP53 alterations in breast carcinoma
|British Journal of Cancer|1993|168